NEOADJUVANT HIGH-DOSE METHOTREXATE, CISPLATIN, AND DOXORUBICIN FOR THE MANAGEMENT OF PATIENTS WITH NONMETASTIC OSTEOSARCOMA

被引：0
|
作者：
WEINER, MA
HARRIS, MB
LEWIS, M
JONES, R
SHERRY, H
FEURER, EJ
JOHNSON, J
LAHMAN, E
机构：
[1] MT SINAI MED CTR,DEPT NEOPLAST DIS,NEW YORK,NY 10029
[2] MT SINAI MED CTR,DEPT ORTHOPED,NEW YORK,NY 10029
[3] MT SINAI MED CTR,DEPT BIOMATH SCI,NEW YORK,NY 10029
[4] HOSP JOINT DIS,INST ORTHOPED,BONE TUMOR SERV,NEW YORK,NY 10003
来源：
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1431 / 1432
页数：2
相关论文
共 50 条
  • [41] Perioperative chemotherapy with and without high-dose methotrexate in adult osteosarcoma
    Negrao, Marcelo Vailati
    da Silva Rocha, Lucila S.
    Girardi, Daniel da Motta
    Feher, Olavo
    ANTI-CANCER DRUGS, 2017, 28 (08) : 915 - 921
  • [42] Pharmacogenetic analysis of high-dose methotrexate treatment in paediatric osteosarcoma
    Hegyi, M.
    Csordas, K.
    Eipel, O.
    Csagoly, E.
    Erdelyi, D. J.
    Semsei, A. F.
    Kovacs, G. T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S353 - S353
  • [43] SARCOIDOSIS FOLLOWING ADJUVANT HIGH-DOSE METHOTREXATE THERAPY FOR OSTEOSARCOMA
    SYBERT, A
    BUTLER, TP
    ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (03) : 488 - 489
  • [44] Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
    Hegyi, Marta
    Arany, Adam
    Semsei, Agnes F.
    Csordas, Katalin
    Eipel, Oliver
    Gezsi, Andras
    Kutszegi, Nora
    Csoka, Monika
    Muller, Judit
    Erdelyi, Daniel J.
    Antal, Peter
    Szalai, Csaba
    Kovacs, Gabor T.
    ONCOTARGET, 2017, 8 (06) : 9388 - 9398
  • [45] Effect of dose intensity of methotrexate, doxorubicin, and ifosfamide on the prognosis of patients with osteosarcoma
    Uchida Y.
    Ozaki T.
    Kawai A.
    Kunisada T.
    Dan'ura T.
    Naito N.
    Inoue H.
    International Journal of Clinical Oncology, 1999, 4 (1) : 36 - 40
  • [46] High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma - Incidence, treatment, and outcome
    Widemann, BC
    Balis, FM
    Kempf-Bielack, B
    Bielack, S
    Pratt, CB
    Ferrari, S
    Bacci, G
    Craft, AW
    Adamson, PC
    CANCER, 2004, 100 (10) : 2222 - 2232
  • [47] Ambulatory High-dose Methotrexate Administration in Pediatric Osteosarcoma Patients at a Single Institution in Argentina
    Rubio, Jose A. Villegas
    Cacciavillano, Walter
    Rose, Adriana
    Zubizarreta, Pedro
    Scopinaro, Marcelo
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (07) : E349 - E352
  • [48] AMBULATORY HIGH-DOSE METHOTREXATE ADMINISTRATION IN PEDIATRIC OSTEOSARCOMA PATIENTS AT A SINGLE INSTITUTION IN ARGENTINA
    Villegas Rubio, Jose Antonio
    Cacciavillano, Walter
    Rose, Adriana
    Sampor, Claudia
    Guitter, Myriam
    Alfaro, Elizabeth
    Zubizarreta, Pedro
    Scopinaro, Marcelo
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 777 - 778
  • [49] EXPERIENCE WITH PREOPERATIVE, HIGH-DOSE METHOTREXATE (HDMTX) CONTAINING CHEMOTHERAPY IN PATIENTS WITH OSTEOSARCOMA (OSA)
    HONEGGER, HP
    CSERHATI, MD
    VONHOCHSTETTER, A
    HOFMANN, V
    GROSCURTH, P
    CANCER DRUG DELIVERY, 1986, 3 (01): : 69 - 69
  • [50] Population Pharmacokinetics of High-Dose Methotrexate After Intravenous Administration in Pediatric Patients With Osteosarcoma
    Colom, Helena
    Farre, Rosa
    Soy, Dolors
    Peraire, Concepcion
    Cendros, Josep-Maria
    Pardo, Nuria
    Torrent, Montserrat
    Domenech, Josep
    Mangues, Maria-Antonia
    THERAPEUTIC DRUG MONITORING, 2009, 31 (01) : 76 - 85
12345